These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z, French Histiocytoses Study Group. Blood; 2014 Aug 14; 124(7):1119-26. PubMed ID: 24894769 [Abstract] [Full Text] [Related]
16. Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity. Paxton CN, O'Malley DP, Bellizzi AM, Alkapalan D, Fedoriw Y, Hornick JL, Perkins SL, South ST, Andersen EF. Mod Pathol; 2017 Sep 14; 30(9):1234-1240. PubMed ID: 28752840 [Abstract] [Full Text] [Related]
17. BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. Janku F, Vibat CR, Kosco K, Holley VR, Cabrilo G, Meric-Bernstam F, Stepanek VM, Lin PP, Leppin L, Hassaine L, Poole JC, Kurzrock R, Erlander MG. Oncotarget; 2014 Jun 15; 5(11):3607-10. PubMed ID: 25003820 [Abstract] [Full Text] [Related]
18. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan MH, Liang ZY, Zhou DB. Ann Hematol; 2016 Apr 15; 95(5):745-50. PubMed ID: 26858028 [Abstract] [Full Text] [Related]
19. BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. Bellinato F, Maurelli M, Colato C, Balter R, Girolomoni G, Schena D. Br J Dermatol; 2019 Apr 15; 180(4):933-934. PubMed ID: 30430550 [No Abstract] [Full Text] [Related]